$4.85 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 127 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 58.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AHCO | Sell | ADAPTHEALTH CORP | $201,160,000 | +7.7% | 11,150,797 | -4.3% | 4.15% | -0.6% |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $63,137,000 | -12.7% | 3,244,434 | -1.2% | 1.30% | -19.4% |
| LUNG | Sell | PULMONX CORP | $51,018,000 | -44.4% | 3,465,901 | -6.2% | 1.05% | -48.7% |
| KURA | Sell | KURA ONCOLOGY INC | $48,153,000 | -32.2% | 2,627,000 | -40.5% | 0.99% | -37.5% |
| PHVS | Sell | PHARVARIS N V | $26,307,000 | -8.0% | 1,190,343 | -24.5% | 0.54% | -15.0% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $24,965,000 | -49.0% | 313,000 | -32.7% | 0.52% | -52.9% |
| OMIC | Sell | SINGULAR GENOMICS SYSTEMS IN | $24,205,000 | -42.0% | 6,336,330 | -4.2% | 0.50% | -46.5% |
| BLU | Sell | BELLUS HEALTH INC NEW | $22,851,000 | -9.6% | 2,473,000 | -32.7% | 0.47% | -16.6% |
| ORGO | Sell | ORGANOGENESIS HLDGS INC | $21,705,000 | -66.3% | 4,447,740 | -47.4% | 0.45% | -68.9% |
| ATEC | Sell | ALPHATEC HLDGS INC | $15,830,000 | -61.7% | 2,420,547 | -32.7% | 0.33% | -64.6% |
| KNTE | Sell | KINNATE BIOPHARMA INC | $3,153,000 | -71.6% | 250,000 | -74.6% | 0.06% | -73.8% |
| MDVL | Sell | MEDAVAIL HOLDINGS INC | $1,280,000 | +15.3% | 836,626 | -26.8% | 0.03% | +4.0% |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -470 | -100.0% | 0.00% | – |
| BCAB | Exit | BIOATLA INC | $0 | – | -289,002 | -100.0% | -0.03% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -391,115 | -100.0% | -0.04% | – |
| Exit | NEOGENOMICS INCnote 0.250% 1/1 | $0 | – | -2,500,000 | -100.0% | -0.04% | – | |
| GKOS | Exit | GLAUKOS CORPcall | $0 | – | -45,200 | -100.0% | -0.06% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -375,585 | -100.0% | -0.09% | – |
| VINC | Exit | VINCERX PHARMA INC | $0 | – | -1,379,310 | -100.0% | -0.12% | – |
| Exit | BENEFITFOCUS INCnote 1.250%12/1 | $0 | – | -6,500,000 | -100.0% | -0.14% | – | |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -2,345,959 | -100.0% | -0.16% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -830,472 | -100.0% | -0.27% | – |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -249,988 | -100.0% | -0.32% | – |
| Exit | OAK STR HEALTH INCnote 3/1 | $0 | – | -18,000,000 | -100.0% | -0.32% | – | |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -1,012,000 | -100.0% | -0.37% | – |
| NUVB | Exit | NUVATION BIO INC | $0 | – | -3,577,233 | -100.0% | -0.42% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -979,106 | -100.0% | -0.42% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -270,000 | -100.0% | -0.50% | – |
| Exit | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $0 | – | -80,000,000 | -100.0% | -1.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.